Kevin Caliendo
Stock Analyst at UBS
(4.55)
# 243
Out of 4,893 analysts
183
Total ratings
72.73%
Success rate
12.34%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $400 → $385 | $299.51 | +28.54% | 12 | Jun 25, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $8.5 | $4.73 | +79.70% | 4 | May 27, 2025 | |
| ZIMV ZimVie | Maintains: Neutral | $16 → $10 | $9.41 | +6.33% | 1 | May 15, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $6 → $5.25 | $4.90 | +7.14% | 4 | May 13, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $27 → $25 | $16.62 | +50.42% | 10 | May 9, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $15 | $11.23 | +33.57% | 3 | May 9, 2025 | |
| AMWL American Well | Maintains: Neutral | $12 → $9 | $8.39 | +7.27% | 3 | May 8, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $21 → $18 | $20.72 | -13.13% | 3 | May 5, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $16 → $17 | $13.38 | +27.06% | 7 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $160 → $170 | $162.17 | +4.83% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $71 | $65.62 | +8.20% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $708 → $805 | $714.54 | +12.66% | 14 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $297.32 | +12.67% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $204.48 | +5.14% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $83 → $80 | $74.53 | +7.35% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $13 | $8.28 | +57.00% | 5 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $330 → $305 | $228.58 | +33.43% | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $308.78 | +26.30% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $170 | $171.45 | -0.85% | 13 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $293 → $286 | $253.63 | +12.76% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.56 | -13.49% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $232.18 | +7.68% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $32.52 | +142.93% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $21.48 | +21.07% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $345.86 | +66.25% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $157.69 | +14.15% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.81 | +717.25% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $16.53 | -33.45% | 4 | May 4, 2021 |
UnitedHealth Group
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $299.51
Upside: +28.54%
LifeStance Health Group
May 27, 2025
Upgrades: Buy
Price Target: $8.5
Current: $4.73
Upside: +79.70%
ZimVie
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $9.41
Upside: +6.33%
GoodRx Holdings
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $4.90
Upside: +7.14%
DENTSPLY SIRONA
May 9, 2025
Maintains: Buy
Price Target: $27 → $25
Current: $16.62
Upside: +50.42%
Evolent Health
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $11.23
Upside: +33.57%
American Well
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $8.39
Upside: +7.27%
Envista Holdings
May 5, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $20.72
Upside: -13.13%
Alignment Healthcare
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $13.38
Upside: +27.06%
Cardinal Health
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $162.17
Upside: +4.83%
May 2, 2025
Maintains: Neutral
Price Target: $67 → $71
Current: $65.62
Upside: +8.20%
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $714.54
Upside: +12.66%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $297.32
Upside: +12.67%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $204.48
Upside: +5.14%
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $74.53
Upside: +7.35%
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $8.28
Upside: +57.00%
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $228.58
Upside: +33.43%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $308.78
Upside: +26.30%
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $171.45
Upside: -0.85%
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $253.63
Upside: +12.76%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.56
Upside: -13.49%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $232.18
Upside: +7.68%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $32.52
Upside: +142.93%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $21.48
Upside: +21.07%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $345.86
Upside: +66.25%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $157.69
Upside: +14.15%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.81
Upside: +717.25%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $16.53
Upside: -33.45%